Palisade Bio PALI
NASDAQ PALI
$1.43 +0.09 (+6.72%)
At close: Oct 20, 2026 · 4:00 PM EDT

Palisade Bio (PALI) Restructuring Costs (2022 - 2023)

Updated

Palisade Bio's Restructuring Costs was $225,000 in Q4 2023.

Analysis

Palisade Bio (PALI) Restructuring Costs (2022 - 2023) Analysis & Trends

  • In earlier years, Restructuring Costs was $410,000 in FY2022.
  • The Q4 2023 figure marks the highest quarterly Restructuring Costs since Q3 2022.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn
10 Palisade Bio 299.11 Mn -97.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 225,000.00
Sep 30, 2022 410,000.00
API Access

Palisade Bio Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=PALI&period=max&api_key=YOUR_API_KEY